Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Money matters in epilepsy.

S V Thomas1

  • 1Department of Neurology, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum, 695011, India.

Neurology India
|January 9, 2001
PubMed
Summary
This summary is machine-generated.

The rising cost of epilepsy care, particularly newer drugs and surgery, necessitates careful economic evaluation. While newer treatments offer benefits, their cost-effectiveness varies, especially for intractable seizures and quality of life improvements.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hippocampal activations in mesial temporal lobe epilepsy due to hippocampal sclerosis- an observational study on intramural encoding-delayed recall paradigms using task-based memory fMRI.

Epilepsy research·2018
Same author

Hereditary ataxias : from phenotype to genotype.

Neurology India·2018
Same author

Reduced brain volumes in children of women with epilepsy: A neuropsychological and voxel based morphometric analysis in pre-adolescent children.

Journal of neuroradiology = Journal de neuroradiologie·2018
Same author

Long-term visual outcome in idiopathic intracranial hypertension.

Annals of Indian Academy of Neurology·2011
Same author

Central nervous system tuberculosis.

African health sciences·2011
Same author

Accidents and injuries in people with epilepsy attending a tertiary care center in India.

Epileptic disorders : international epilepsy journal with videotape·2008
Same journal

A Life in Service of Neuroscience, Healing, and Teaching.

Neurology India·2026
Same journal

IN MEMORIAM.

Neurology India·2026
Same journal

Extensive Diffusion Restriction of White Matter, Midbrain, and Basal ganglia in a Neonate with Refractory Hypoglycemic Seizures.

Neurology India·2026
Same journal

CHD2-Related Developmental Epileptic Encephalopathy and Angelman Syndrome in a Girl: A Double Jeopardy.

Neurology India·2026
Same journal

Cerebral Schistosomiasis Mimicking Multiple Intracranial Metastases.

Neurology India·2026
Same journal

Extrusion of Spinal Implants Through the Overlying Skin: A Rare Epiphenomenon of Metal Allergy.

Neurology India·2026
See all related articles

Area of Science:

  • Health Economics
  • Neurology
  • Pharmacoeconomics

Background:

  • Epilepsy care costs have significantly increased due to newer anti-epileptic drugs (AEDs) and advanced treatment strategies.
  • Direct medical costs include expensive newer AEDs, presurgical evaluations, and epilepsy surgery.
  • Indirect societal costs, such as lost productivity and premature mortality, far exceed direct medical expenses.

Purpose of the Study:

  • To discuss the economic appraisal principles for epilepsy management.
  • To evaluate the cost-effectiveness of newer epilepsy treatments versus conventional ones.
  • To provide physicians with data for informed practice regarding epilepsy interventions.

Main Methods:

  • Review of economic appraisal principles in epilepsy care.

Related Experiment Videos

  • Analysis of cost-benefit and cost-utility of newer AEDs and surgical interventions.
  • Discussion of existing literature on the economic impact of epilepsy treatments.

    • Main Results:

    • Newer AEDs may not justify increased costs in unselected epilepsy populations but show superiority in intractable cases.
    • The high initial costs of presurgical evaluation and epilepsy surgery can be offset by improved quality-adjusted life years.
    • Limited data currently exists for physicians to guide economic decision-making in epilepsy practice.

    Conclusions:

    • Economic evaluation is crucial for assessing the true utility of epilepsy interventions.
    • Cost-effectiveness of newer epilepsy treatments is context-dependent, particularly for specific patient subgroups.
    • Further research and data are needed to support evidence-based economic decision-making in clinical epilepsy management.